BIOXYTRAN, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/25e43a21-fc9e-4cc1-a178-44c330ab6129/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.8M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-016798 |
| FY 2024 | $-2.2M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-002614 |
| FY 2023 | $-3.8M | 2023-01-01 – 2023-12-31 | evidence 0001493152-25-001889 |
| FY 2022 | $-2.4M | 2022-01-01 – 2022-12-31 | evidence 0001493152-25-001889 |
| FY 2021 | $-4.2M | 2021-01-01 – 2021-12-31 | evidence 0001539497-22-000793 |
| FY 2020 | $-1.3M | 2020-01-01 – 2020-12-31 | evidence 0001785982-21-000076 |
| FY 2019 | $-1.6M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-006766 |
| FY 2018 | $-215.1k | 2018-01-01 – 2018-12-31 | evidence 0001213900-20-006766 |
| FY 2017 | $-310.6k | 2017-01-01 – 2017-12-31 | evidence 0001213900-18-003761 |
| FY 2016 | $-671.3k | 2016-01-01 – 2016-12-31 | evidence 0001213900-17-003123 |
| FY 2015 | $-2.1M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-015178 |
| FY 2014 | $-1.3M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002590 |
| FY 2013 | $-2.0M | 2013-01-01 – 2013-12-31 | evidence 0001213900-14-002358 |
| FY 2012 | $-2.3M | 2012-01-01 – 2012-12-31 | evidence 0001213900-13-001783 |
| FY 2011 | $-5.5M | 2008-06-09 – 2012-03-31 | evidence 0001213900-13-000275 |
| FY 2010 | $-329.0k | 2010-01-01 – 2010-12-31 | evidence 0001213900-12-001182 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).